company

YPSOMED AS

3045 DRAMMEN

Return on Equity
0,1 %
Current Ratio
4,68
Debt-to-Equity Ratio
0
Key figures (NOK)2023
Revenue3 309 000
Net Income2 000
Total Assets2 550 000
Total Equity2 005 000
Income (NOK)2023
Revenue3 309 000
Expenditure3 303 000
Operating Profit6 000
Financial Income1 000
Financial Costs3 000
Financial Balance−2 000
Earnings Before Tax3 000
Tax2 000
Net Income2 000
Balance (NOK)2023
Total Fixed Assets0
Total Current Assets2 550 000
Total Assets2 550 000
Total Retained Equity5 000
Total Equity2 005 000
Total Long-Term Debt0
Total Current Debt545 000
Total Equity and Debt2 550 000
Cash flow (NOK)2023
Sales Income173 000
Other Income3 136 000
Revenue3 309 000
Cost of Goods Sold63 000
Salary Costs2 635 000
Depreciation0
Impairment0
Expenditure3 303 000
Operating Profit6 000
Financial Income1 000
Financial Costs3 000
Financial Balance−2 000
Dividends0
Net Income2 000
Balance details (NOK)2023
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock16 000
Total Investments0
Cash, Bank959 000
Total Current Assets2 550 000
Total Assets2 550 000
Total Equity2 005 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors15 000
Unpaid Taxes85 000
Dividends0
Other Current Debt443 000
Total Current Debt545 000
Total Equity and Debt2 550 000
Financial indicators2023
Return on Equity0,1 %
Debt-to-Equity Ratio0
Operating Profit Margin0,18 %
Current Ratio4,68
Quick Ratio4,82
Equity Ratio0,79
Gross Profit Margin98,1 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English